Egyptian Journal of Radiology and Nuclear Medicine

Table 1 Demonstrates the statistical significance of IPSS and QoL changes post sclerotherapy

From: Role of varicocele sclerotherapy in the management of benign prostatic hyperplasia and its associated lower urinary tract symptoms (pilot study)

	Pre	Post	Test value	P value	Sig
	No. = 36	No. = 36	Test value	P value	Sig
IPSS scores
Median (IQR)	19 (15–22.5)	17 (7–19)	− 2.425^‡	0.015	S
Range	7–30	6–35	− 2.425^‡	0.015	S
IPSS grades
Mild (1–7)	3 (8.3%)	9 (25.0%)	13.130*	0.004	HS
Moderate (8–19)	18 (50.0%)	15 (41.7%)
Severe (20–35)	15 (41.7%)	6 (16.7%)
NA	0 (0.0%)	6 (16.7%)
QOL
Median (IQR)	5 (4–6)	4 (4–6)	− 2.546^‡	0.011	S
Range	3–6	2–6	− 2.546^‡	0.011	S

P value > 0.05: non significant (NS); P value < 0.05: significant (S); P value < 0.01: highly significant (HS)
*Chi-square test
^‡Wilcoxon Rank test

Back to article page